Cyril Amarchand Mangaldas advised Organon & Co. (NYSE: OGN), a global healthcare company, with diverse portfolio across women’s health, biosimilars, and therapies and products for a wide range of conditions and diseases, in its acquisition by Sun Pharmaceutical Holdings USA, Inc., a U.S. subsidiary of Sun Pharmaceutical Industries Ltd (NSE: SUNPHARMA), the leading pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.
The transaction team was led by Ruetveij Pandya, Partner; and Saloni Shroff, Partner; with assistance from Abhilasha Malpani, Principal Associate; Sajith Anjickal, Chelsea Sawlani, Neelanshi Gupta, Simran Srivastava, and Shravan Subramanian, Associates. Rishabh Shroff, Partner (Co-Head - Private Client and Head - International Business Development); provided strategic inputs and guidance. Meeta Kurpad, Partner; with support from Manasvin Andra, Associate; advised on financing aspects of the transaction.
About Cyril Amarchand Mangaldas
Cyril Amarchand Mangaldas (CAM) is India’s leading law firm with a global reputation of being trusted advisers to its clients. The Firm advises a large and diverse set of clients, including domestic and foreign commercial enterprises, financial institutions, private equity and venture capital funds, start-ups, government and regulatory bodies. The Firm’s generalists, specialists and senior ex-regulators expertly guide clients across a spectrum of transactions, sectors and regulations. With over 1400 lawyers including 220 Partners, the Firm is a full-service law firm with offices in key business centres at Mumbai, Delhi-NCR, Bengaluru, Ahmedabad, Hyderabad, Chennai, GIFT City, Singapore and Abu Dhabi.
The Firm has been named “Law Firm of the Year 2025” and consistently recognised as “Best Overall Law Firm” by the IBLJ Indian Law Firm Awards. It received “National Law Firm of the Year: India” at the IFLR Asia-Pacific Awards for the second consecutive year in 2023 and 2022 and “Innovation in Advancing Markets” award at the FT Innovative Lawyers Asia Pacific 2022 Awards. The Firm also won “India Deal Firm of the Year” at the ALB India Awards and “Firm of the Year” at the IFLR1000 India Awards in 2022.
Picture Source :